Korean Circ J.  2016 Jul;46(4):468-471. 10.4070/kcj.2016.46.4.468.

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?

• Habon T
• Toth K

• KMID: 2344420
• DOI: http://doi.org/10.4070/kcj.2016.46.4.468

Abstract

No abstract available.

MeSH Terms

Hydroxymethylglutaryl-CoA Reductase Inhibitors*

Reference

1. Wang CY, Liu PY, Liao JK. Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med. 2008; 14:37–44.

2. Rosenson RS. Statin therapy: new therapy for cardiac microvascular dysfunction. Eur Heart J. 2003; 24:1993–1994.

3. Szapary L, Horvath B, Marton Z, et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. CNS Drugs. 2004; 18:165–172.

4. Eisen A, Leshem-Lev D, Yavin H, et al. Effect of High Dose Statin Pretreatment on Endothelial Progenitor Cells After Percutaneous Coronary Intervention (HIPOCRATES Study). Cardiovasc Drugs Ther. 2015; 29:129–135.

5. Lee BK, Koo BK, Nam CW, et al. Does pre-treatment with high dose atorvastatin prevent microvascular dysfunction after percutaneous coronary intervention in patients with acute coronary syndrome? Korean Circ J. 2016; 46:472–480.

6. Pasceri V, Patti G, Nusca A, Pristipino C, Richichi G, Di Sciascio G. ARMYDA Investigators. Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of Myocardial Damage during Angioplasty) study. Circulation. 2004; 110:674–678.

7. Briguori C, Visconti G, Focaccio A, et al. Novel approaches for preventing or limiting events (NAPLES) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. J Am Coll Cardiol. 2009; 54:2157–2163.

8. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation. 2003; 107:3129–3132.

9. Fujii K, Kawasaki D, Oka K, et al. The impact of pravastatin pre-treatment on periprocedural microcirculatory damage in patients undergoing percutaneous coronary intervention. JACC Cardiovasc Interv. 2011; 4:513–520.

10. Eagle KA, Chopra V. Statins before coronary procedures a new indication for an old friend. J Am Coll Cardiol. 2010; 56:1110–1112.

11. Tamai O, Matsuoka H, Itabe H, Wada Y, Kohno K, Imaizumi T. Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans. Circulation. 1997; 95:76–82.

12. Jarcho JA, Keaney JF Jr. Proof that lower is better--LDL cholesterol and IMPROVE-IT. N Engl J Med. 2015; 372:2448–2450.